Obtaining the optimal treatment outcome with tazarotene

Dermatol Nurs. 1998 Oct;10(5):343-8.


Tazarotene topical gel (Tazorac) is a vitamin A derivative and the first topical retinoid to demonstrate therapeutic success in treating plaque-type psoriasis. It has been available in the United States since 1997. Tazarotene offers long-term remission in many patients and may be used in combination with corticosteroids and UVB therapy for even better results. Due to its potency as a vitamin derivative, tazarotene is also associated with irritation in some patients. Patients must be educated about proper application of the drug and realistic expectations for treatment outcome.

MeSH terms

  • Dermatologic Agents / therapeutic use*
  • Gels
  • Humans
  • Nicotinic Acids / therapeutic use*
  • Patient Education as Topic
  • Psoriasis / drug therapy*
  • Psoriasis / pathology
  • Retinoids / therapeutic use*
  • Treatment Outcome


  • Dermatologic Agents
  • Gels
  • Nicotinic Acids
  • Retinoids
  • tazarotene